Chronic degradation of the extracellular matrix, an increase in proinflammatory cytokines (TNF-α, IL-1, IL-6) [16] which inhibit downregulation of the immune response [17], and soft tissue edema interfering with an already impaired underlying PAD all further hinder wound healing. The gene discussed is TNF; the disease is peripheral arterial disease.